In Real Life, Low-Level HER2 Expression May Be Associated With Better Outcome in HER2-Negative Breast Cancer: A Study of the National Cancer Center, China

BACKGROUND: To characterize the clinical and pathological features and survival of patients with human epidermal growth factor receptor 2 (HER2)-low breast cancer in China. METHODS: The China National Cancer Center database was used to identify 1,433 metastatic breast cancer patients with HER2-negat...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yiqun, Abudureheiyimu, Nilupai, Mo, Hongnan, Guan, Xiuwen, Lin, Shaoyan, Wang, Zijing, Chen, Yimeng, Chen, Shanshan, Li, Qiao, Cai, Ruigang, Wang, Jiayu, Luo, Yang, Fan, Ying, Yuan, Peng, Zhang, Pin, Li, Qing, Ma, Fei, Xu, Binghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801428/
https://www.ncbi.nlm.nih.gov/pubmed/35111669
http://dx.doi.org/10.3389/fonc.2021.774577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801428/
https://www.ncbi.nlm.nih.gov/pubmed/35111669
http://dx.doi.org/10.3389/fonc.2021.774577

Ejemplares similares